Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-visit intradermal versus intramuscular Rabipur priming for rabies vaccination in adults
2022-002367-29Phase 3Active
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Aug 2022
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Rabies vaccine in rabies (3 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Boostability at day 7 after booster. Started Aug 2022; status: active.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on 2022-002367-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002367-29.